Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Lexicon Pharmaceuticals (LXRX) Long-Term Debt Issuances (2023)

Lexicon Pharmaceuticals (LXRX) has disclosed Long-Term Debt Issuances for 1 consecutive years, with -$1000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A to -$1000.0 in Q4 2023 year-over-year; TTM through Sep 2024 was $50.0 million, a 0.0% change, with the full-year FY2023 number at $50.0 million, up 2.24% from a year prior.
  • Long-Term Debt Issuances was -$1000.0 for Q4 2023 at Lexicon Pharmaceuticals, down from $1000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $50.0 million in Q2 2023 to a low of -$1000.0 in Q4 2023.